本文選題：自控-靶控鎮(zhèn)痛 + 靶濃度靶控輸注�。� 參考：《廣西醫(yī)科大學(xué)》2015年碩士論文

【摘要】：目的探討應(yīng)用Tivatrainer藥代動(dòng)力學(xué)模擬軟件擬合舒芬太尼自控-靶控輸注技術(shù)(PCA-TCI)在腹腔鏡下婦科手術(shù)術(shù)后鎮(zhèn)痛的有效性和安全性。方法36例ASAI-II級(jí)擇期行腹腔鏡下婦科手術(shù)的患者,用SPSS軟件隨機(jī)分為自控-靶控組(A)和靶控組(B)二組,每組n=18例�；颊咝g(shù)中靶控輸注舒芬太尼和異丙酚,應(yīng)用Tivatainer藥代動(dòng)力學(xué)軟件擬合患者血漿藥物濃度,在血漿靶濃度達(dá)到0.1ng/ml (記為T。)開始上鎮(zhèn)痛泵。在上泵時(shí)(T0)及上泵后T1(30min)、T2 (1h)、T3 (2h)、T4 (4h)、 T5 (6h)、T6(8h)、T7(16h)各時(shí)點(diǎn),記錄Prince-Henry鎮(zhèn)痛評(píng)分、Ramsay鎮(zhèn)靜評(píng)分、生命體征及各時(shí)間舒芬太尼用藥量和不良反應(yīng)發(fā)生情況,并在T0、T2、T4、T6行血?dú)夥治?在各個(gè)時(shí)間點(diǎn)上取得相對(duì)應(yīng)的舒芬太尼血漿靶濃度值。結(jié)果(1)兩組患者一般資料基本一致,無(wú)統(tǒng)計(jì)學(xué)差別。(2)兩組各時(shí)點(diǎn)MAP、HR、RR、SpO2、鼻測(cè)PetC02和血?dú)庵翟谡７秶鷥?nèi)。(3)兩組患者Prince-Henry鎮(zhèn)痛評(píng)分、Ramsay鎮(zhèn)靜評(píng)分差異無(wú)統(tǒng)計(jì)學(xué)意義。(4)A組術(shù)后16小時(shí)各時(shí)點(diǎn)舒芬太尼用藥量明顯低于B組,差異有統(tǒng)計(jì)學(xué)意義。(5)兩組患者上泵后舒芬太尼靶濃度各時(shí)點(diǎn)組間比較有統(tǒng)計(jì)學(xué)差異(P0.05)。A組患者靶濃度低于B組,A組患者的有效濃度為0.07±0.03ng/ml。(6)兩組患者鎮(zhèn)痛過(guò)程中均未出現(xiàn)鎮(zhèn)痛不足、呼吸抑制、惡心嘔吐等不良反應(yīng)。結(jié)論在婦科腔鏡手術(shù)術(shù)后病人鎮(zhèn)痛的研究中,自控-TCI與術(shù)后靶控鎮(zhèn)痛效果區(qū)別不大,都能夠達(dá)到滿意的臨床鎮(zhèn)痛效果,但自控-TCI術(shù)后16h舒芬太尼用藥量明顯減少,能最大限度符合個(gè)體化按需給藥原則。
[Abstract]:Objective to investigate the efficacy and safety of Tivatrainer pharmacokinetic simulation software fitting sufentanil self-controlled and target-controlled infusion technique (PCA-TCII) for postoperative analgesia after laparoscopic gynecological surgery. Methods Thirty-six patients with ASAI-II grade undergoing elective laparoscopic gynecologic surgery were randomly divided into two groups (n = 18 in each group). The patients were randomly divided into two groups: automatic control and target control group (A) and target control group (B). Sufentanil and propofol were injected intraoperatively by target-controlled infusion. The plasma concentration of sufentanil and propofol was fitted by Tivatainer pharmacokinetic software. The target concentration of sufentanil and propofol reached 0.1ng/ml (T.) Start on the analgesic pump. At each time point, the Prince-Henry analgesia score, the vital signs, the dosage and adverse reactions of sufentanil at each time point were recorded, and the blood gas analysis was performed at T0 / T2T4T6. The corresponding plasma target concentrations of sufentanil were obtained at each time point. Results 1) the general data of the two groups were basically the same. There was no significant difference in Prince-Henry analgesia score and Ramsay sedation score between two groups. The dosage of sufentanil at 16 hours after operation in group A was significantly lower than that in group B. There was significant difference between the two groups in the target concentration of sufentanil after the pump. There was statistical difference in the target concentration of sufentanil between the two groups. The target concentration of group A was lower than the effective concentration of group B (0.07 鹵0.03ng / ml. Respiratory inhibition, nausea, vomiting and other adverse reactions. Conclusion in the study of postoperative analgesia of patients undergoing gynecological endoscopic surgery, the effect of patient-controlled TCI and postoperative target-controlled analgesia is not different, both of them can achieve satisfactory clinical analgesic effect, but the dosage of sufentanil at 16 hours after self-controlled TCI is obviously reduced. It can accord with the principle of individualized medicine on demand to the maximum extent.
【學(xué)位授予單位】：廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：R614

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 陳律;李桂云;蔡衛(wèi)新;張雪梅;王玉新;張崢;石廣志;徐明;周建新;;Ramsay評(píng)分在神經(jīng)外科術(shù)后患者中應(yīng)用的信度和效度[J];中國(guó)醫(yī)藥導(dǎo)刊;2011年12期

2 李宇虹;徐凱智;陳晨;許艷榮;靳彥濤;岳靜玲;;國(guó)產(chǎn)舒芬太尼在先天性心臟病與風(fēng)濕性瓣膜病患者藥代動(dòng)力學(xué)比較[J];中國(guó)臨床藥理學(xué)雜志;2012年04期

3 段慶芳;蘭飛;王天龍;;瑞芬太尼致術(shù)后急性疼痛的研究進(jìn)展[J];北京醫(yī)學(xué);2013年08期

4 董慧詠;;瑞芬太尼復(fù)合異丙酚靜脈麻醉臨床研究進(jìn)展[J];河北醫(yī)藥;2007年12期

5 李俊;;霧化吸入起始時(shí)間對(duì)全身麻醉手術(shù)后咽痛緩解的影響探討[J];吉林醫(yī)學(xué);2012年15期

6 趙澤宇;王茜;張倩;李斌;范靈;;舒芬太尼復(fù)合靶控輸注丙泊酚靜脈誘導(dǎo)對(duì)腹腔鏡膽囊切除術(shù)老年患者血流動(dòng)力學(xué)的影響[J];四川醫(yī)學(xué);2010年02期

7 曾春香;;護(hù)理干預(yù)對(duì)全麻患者圍拔管期不良反應(yīng)的影響[J];齊魯護(hù)理雜志;2013年20期

8 金昔陸,池志強(qiáng);μ阿片受體激動(dòng)劑舒芬太尼的藥理作用和應(yīng)用[J];中國(guó)現(xiàn)代應(yīng)用藥學(xué);1999年01期

9 楊程;陳寧;;麻醉靶控輸注新進(jìn)展[J];醫(yī)療衛(wèi)生裝備;2012年02期

10 錢裕方;;阿片類鎮(zhèn)痛藥的臨床合理用藥分析[J];中國(guó)社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè));2012年20期

相關(guān)會(huì)議論文 前2條

1 葉飛;佘守章;許學(xué)兵;;子宮切除術(shù)后舒芬太尼病人自控-靶控鎮(zhèn)痛的安全性和有效性[A];中華醫(yī)學(xué)會(huì)疼痛學(xué)分會(huì)第八屆年會(huì)暨CASP成立二十周年論文集[C];2009年

2 任祖華;韋云婷;李麗軍;陳騰高;;經(jīng)肛門粘膜環(huán)切術(shù)后舒芬太尼病人自控-靶控鎮(zhèn)痛的安全性和有效性[A];浙江省醫(yī)學(xué)會(huì)疼痛學(xué)分會(huì)成立大會(huì)暨首屆浙江省醫(yī)學(xué)會(huì)疼痛學(xué)分會(huì)學(xué)術(shù)年會(huì)論文匯編[C];2011年

相關(guān)碩士學(xué)位論文 前5條

1 鄧U，

本文編號(hào)：1857183